Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura - Concepedia

Concepedia

Publication | Open Access

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura

DOI Full Paper Access

42

Citations

21

References

2023

Year

Linus A. Völker, Jessica Kaufeld, Gesa Balduin, Lena Merkel, Lucas Kühne, Dennis A. Eichenauer, Thomas Osterholt, Holger Hägele, Martin Kann, Franziska Grundmann,

Journal of Thrombosis and Haemostasis

First-line UseThrombosisThrombopoiesisAutoimmune DiseaseBlood PlateletHematologyImmunologyAutoimmunityImmunotherapyMedicineTreatment Outcomes

References

	Year	Citations

Page 1

Page 1